Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;48(9):e414-e431.
doi: 10.1111/1346-8138.16067. Epub 2021 Jul 27.

2020 guidelines for the diagnosis and treatment of prurigo

Affiliations

2020 guidelines for the diagnosis and treatment of prurigo

Takahiro Satoh et al. J Dermatol. 2021 Sep.

Abstract

Prurigo is a treatment-resistant skin disease characterized by multiple isolated papules/nodules that cause severe itch. Prurigo papules/nodules occur either as primary lesions or as secondary lesions due to persistent scratching. The fundamental concepts and classifications of prurigo have not been sufficiently established, and considerable confusion remains regarding this topic. Clinical guidelines for chronic prurigo in Japan were published in 2012 in an attempt to reduce confusion regarding the concepts of prurigo and to standardize laboratory tests and treatments. However, the diagnostic terms for prurigo and associated concepts have changed over time, and new forms of treatment are under development. We have, thus, updated and revised the guidelines to classify prurigo based on clinical forms and causes, and disease name classifications based on the clinical form have been further simplified, such as prurigo nodularis, prurigo chronica multiformis, and prurigo (not otherwise specified). Expressions for acute, subacute, and chronic forms are not used. These guidelines outline the current concepts and specify treatments for prurigo.

Keywords: classifications; prurigo chronica multiformis prurigo nodularis; prurigo not otherwise specified; treatments.

PubMed Disclaimer

References

REFERENCES

    1. Doyle JA, Connolly SM, Hunziker N, Winkelmann RK. Prurigo nodularis, a reappraisal of the clinical and histologic features. J Cutan Pathol. 1979;6:392-403.
    1. Iking A, Grudmann S, Chatzigerorgakidis E, Phan NQ, Klein D, Ständer S. Prurigo as a symptom of atopic and non-atopic diseases: aetiology survey in a consecutive cohort of 108 patients. J Eur Acad Dermatol Venereol. 2013;27:550-07.
    1. Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. J Epidemiol Community Health. 1976;30:107-14.
    1. Furue M, Yamazaki S, Jimbo K, Tsuchida T, Amagai M, Tanaka T. Nationwide cross-sectional and seasonal multicenter study of dermatological patients in Japan. Jpn J Dermatol. 2009;119:1795-809. (In Japanese).
    1. Murota H, Kitaba S, Tani M, Kaneda M, Umegaki N, Katayama I. Assessments of labor productivity in skin disease patients with pruritus and investigations of improvement effects through histamine H1 antagonists. Prog Med. 2009;29:1842-8. (In Japanese).

LinkOut - more resources